SlideShare uma empresa Scribd logo
1 de 26
BAFF, Linfocitos B y Autoinmunidad ,[object Object],[object Object]
REAPPRAISAL OF BAFF IN AUTOIMMUNE CONDITIONS Pierre Youinou European University of Brittany, Brest, France
T NF-like   WEAK   inducer of apoptosis   ( TWEAK ) A   Pr oliferation   I nducing   L igand ( APRIL ) B -cell   A ctivation  F actor of the TNF  F amily   ( BAFF ) TUMOR NECROSIS FACTOR FAMILY
 
SETTING  THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
THE CELL SOURCES OF BAFF Monocytes Macrophages Astrocytes Synoviocytes Dendritic cells Activated T lymphocyte Epithelial cells Neutrophils
BR3 TACI BCMA HSPG BAFF SPECIFIC AND NON-SPECIFIC RECEPTORS APRIL BAFF BAFF APRIL APRIL Simone Forest 2010
A VARIETY OF MOLECULES Furin BAFF APRIL TWEAK-PRIL TWEAK Daridon, Youinou et al, Autoimmun Rev 2007
OVEREXPRESSION OF BAFF IN AUTOIMMUNE DISEASES Number of sera tested Proportion with increased level 94 192 126 52 57 2 Systemic lupus erythematosus patients Autoimmune disease controls Normal controls
BAFF IS NOT Stohl et al, Arthritis Rheum 2003 Day of observation Day of observation Persistently elevated serum BAFF Intermittently elevated serum BAFF CONSTANT
BAFF IS NOT ,[object Object],[object Object],[object Object],ACCESSIBLE
Menbrane-bound Cell-free BAFF APRIL Glycosylated or not - + PNGaseF 28 21 Anti-BAFF Complexes Virus-like clusters Rochas, Youinou et al, Arthritis Rheum, 2009 Roschke et al, J Immunol, 2004 Le Pottier, Youinou et al, submitted Liu et al, Cell, 2002 BAFF ? Receptor for BAFF Alternative splices 28 17 TFMS - + Rabbit - + Goat BAFF IS NOT RECOGNIZED
IN-HOUSE ELISA FOR BAFF Le Pottier, Youinou et al, Clin Chem 2009 28 21 S#1 S#2 Rabbit Ab S#1 S#2 Mouse Ab 28 21 Absorbance (492nm) 0 1 2 3 BAFF (  g/L) 0.1 1 10 100 Goat  /  Rabbit-biot Goat  /  Goat-biot Rabbit / Rabbit-biot Rabbit / Goat-biot
SETTING THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
BAFF-MEDIATED B-CELL HOMEOSTASIS PROLIFERATION BAFF Tg TNF-/- BAFF Tg DIFFERENTIATION CD40-dependent CD40 +IL-4 BAFF CD40-independent BAFF no BAFF yes SSC SURVIVAL ACTIVATION
BT1 BT2 High affinity BCR Low affinity BCR Lymphoid follicle germinal center Marginal zone Pre-B MARGINAL ZONE B CELLS AT RISK OF BEING ACTIVATED Apoptosis BAFF
MICE TRANSFECTED WITH cDNA FOR HUMAN BAFF Groom, Mackay et al, J Clin Invest 2002 1/1280
Walters et al, J Immunol, 2009 BAFF-INDUCED REGULATORY T CELLS WT BAFF-Tg CD4 +  Foxp3 +
SETTING THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
DISCOVERY OF A NEW mRNA FOR BAFF 3’ RACE-PCR ? Exon 5  Exon 3  748 862 Δ 4 BAFF 1 2 4 3 5 6 BAFF Δ  BAFF φ BAFF
Δ 4 (D->124) LOCATION OF THE NEW PROTEIN GFP Δ 4 RAMOS BAFF pIRES Δ 4 WT 21 kDa 17 kDa Mouse anti-BAFF Rabbit anti-BAFF BAFF Δ 4  BAFF
Cold probe (20x) Mouse  anti-BAFF Nuclear extract - - - - + - - + - - - + - + - + Rabbit  Anti-BAFF - - + + Supershift Shift Δ 4BAFF IS A TRANSCRIPTION FACTOR
TRUNCATED BAFF  TRANSPORTS TRANSCRIPTION FACTOR(S) FOR  FULL-LENGTH BAFF INTO THE NUCLEUS Le Pottier, Tob ón, Mackay,  Youinou and Pers , submitted Rabbit Mouse -1600 ATG CD40 NF- κ B subunits Negative control Positive control  actin Mouse Plas Δ 4 wt Mouse/ β -actin 0.85 0.90 1.24 0.86 Rabbit Rabbit/ β -actin 0.83 0.90 1.57 0.70 1 1
mRNA for  Δ 4 BAFF Δ 4 BAFF protein product Full-length BAFF Transcription factor
SUMMARY ,[object Object],[object Object],[object Object]
 

Mais conteúdo relacionado

Mais procurados

Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVSergio Exopol
 
Local Genes, for Local Bacteria
Local Genes, for Local BacteriaLocal Genes, for Local Bacteria
Local Genes, for Local BacteriaBen Pascoe
 
L13 functional and_comparative_genomics
L13 functional and_comparative_genomicsL13 functional and_comparative_genomics
L13 functional and_comparative_genomicsMUBOSScz
 
Status of Cassava Genetic Transformation at CIAT.
Status of Cassava Genetic Transformation at CIAT. Status of Cassava Genetic Transformation at CIAT.
Status of Cassava Genetic Transformation at CIAT. CIAT
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...Laurence Dawkins-Hall
 
Ph.D. Candidate Exam Slides
Ph.D. Candidate Exam SlidesPh.D. Candidate Exam Slides
Ph.D. Candidate Exam SlidesBongsoo Park
 
Respiratory pathogens in an intensive poultry farm in Debre Zeit, Ethiopia
Respiratory pathogens in an intensive poultry farm in Debre Zeit, EthiopiaRespiratory pathogens in an intensive poultry farm in Debre Zeit, Ethiopia
Respiratory pathogens in an intensive poultry farm in Debre Zeit, EthiopiaILRI
 
The use of reverse genetics to facilitate the growth of FMDV for the product...
The use of reverse genetics to  facilitate the growth of FMDV for the product...The use of reverse genetics to  facilitate the growth of FMDV for the product...
The use of reverse genetics to facilitate the growth of FMDV for the product...EuFMD
 
2009 CSBB LAB 新生訓練
2009 CSBB LAB 新生訓練2009 CSBB LAB 新生訓練
2009 CSBB LAB 新生訓練Abner Huang
 
Managment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative InfectionsManagment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative InfectionsYazan Kherallah
 
SIV 2012 Anticoli S. def
SIV 2012 Anticoli S. defSIV 2012 Anticoli S. def
SIV 2012 Anticoli S. defSimona Anticoli
 
Exp3 lab report revised
Exp3 lab report revisedExp3 lab report revised
Exp3 lab report revisedJason Gramling
 
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...EuFMD
 
Nanobiotec luminex assay
Nanobiotec luminex assayNanobiotec luminex assay
Nanobiotec luminex assayNANOBIOTEC LLC
 
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...African Potato Association (APA)
 
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...EuFMD
 
SIDiLV Arnal virulence factors
SIDiLV Arnal virulence factorsSIDiLV Arnal virulence factors
SIDiLV Arnal virulence factorsSergio Exopol
 

Mais procurados (19)

Poster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDVPoster benito SIDiLV BVD/BDV
Poster benito SIDiLV BVD/BDV
 
Local Genes, for Local Bacteria
Local Genes, for Local BacteriaLocal Genes, for Local Bacteria
Local Genes, for Local Bacteria
 
L13 functional and_comparative_genomics
L13 functional and_comparative_genomicsL13 functional and_comparative_genomics
L13 functional and_comparative_genomics
 
parth vavadia
parth vavadiaparth vavadia
parth vavadia
 
Status of Cassava Genetic Transformation at CIAT.
Status of Cassava Genetic Transformation at CIAT. Status of Cassava Genetic Transformation at CIAT.
Status of Cassava Genetic Transformation at CIAT.
 
Hungary2002
Hungary2002Hungary2002
Hungary2002
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
 
Ph.D. Candidate Exam Slides
Ph.D. Candidate Exam SlidesPh.D. Candidate Exam Slides
Ph.D. Candidate Exam Slides
 
Respiratory pathogens in an intensive poultry farm in Debre Zeit, Ethiopia
Respiratory pathogens in an intensive poultry farm in Debre Zeit, EthiopiaRespiratory pathogens in an intensive poultry farm in Debre Zeit, Ethiopia
Respiratory pathogens in an intensive poultry farm in Debre Zeit, Ethiopia
 
The use of reverse genetics to facilitate the growth of FMDV for the product...
The use of reverse genetics to  facilitate the growth of FMDV for the product...The use of reverse genetics to  facilitate the growth of FMDV for the product...
The use of reverse genetics to facilitate the growth of FMDV for the product...
 
2009 CSBB LAB 新生訓練
2009 CSBB LAB 新生訓練2009 CSBB LAB 新生訓練
2009 CSBB LAB 新生訓練
 
Managment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative InfectionsManagment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative Infections
 
SIV 2012 Anticoli S. def
SIV 2012 Anticoli S. defSIV 2012 Anticoli S. def
SIV 2012 Anticoli S. def
 
Exp3 lab report revised
Exp3 lab report revisedExp3 lab report revised
Exp3 lab report revised
 
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...
COMPARISON OF USE OF PRIMARY CELLS AND CELL LINES FOR VIRUS ISOLATION ASSAYS ...
 
Nanobiotec luminex assay
Nanobiotec luminex assayNanobiotec luminex assay
Nanobiotec luminex assay
 
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
 
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...
OS18 - 8.a.2 Rational Design of Attenuated FMDV Vaccines by elevation of –Cpg...
 
SIDiLV Arnal virulence factors
SIDiLV Arnal virulence factorsSIDiLV Arnal virulence factors
SIDiLV Arnal virulence factors
 

Destaque

Enflasyon muhasebesi
Enflasyon muhasebesiEnflasyon muhasebesi
Enflasyon muhasebesiMurat Vurgun
 
அருள் நிறைந்த ரமழான்
அருள் நிறைந்த ரமழான்அருள் நிறைந்த ரமழான்
அருள் நிறைந்த ரமழான்wamysl
 
Asma-e-Hasna Seekaho Aur Uk Fazail
Asma-e-Hasna Seekaho Aur Uk FazailAsma-e-Hasna Seekaho Aur Uk Fazail
Asma-e-Hasna Seekaho Aur Uk FazailFaryal Shah
 
20131028 BTUG.be - BizTalk Deployment
20131028 BTUG.be - BizTalk Deployment20131028 BTUG.be - BizTalk Deployment
20131028 BTUG.be - BizTalk DeploymentBTUGbe
 
Internship presentation for sedf
Internship presentation for sedfInternship presentation for sedf
Internship presentation for sedfiqra junejo
 

Destaque (10)

Enflasyon muhasebesi
Enflasyon muhasebesiEnflasyon muhasebesi
Enflasyon muhasebesi
 
O polêmico rolêzinho
O polêmico rolêzinhoO polêmico rolêzinho
O polêmico rolêzinho
 
Sldf 009
Sldf 009Sldf 009
Sldf 009
 
Cy 926 set
Cy 926 setCy 926 set
Cy 926 set
 
Ne kashf shobohat
Ne kashf shobohatNe kashf shobohat
Ne kashf shobohat
 
அருள் நிறைந்த ரமழான்
அருள் நிறைந்த ரமழான்அருள் நிறைந்த ரமழான்
அருள் நிறைந்த ரமழான்
 
Asma-e-Hasna Seekaho Aur Uk Fazail
Asma-e-Hasna Seekaho Aur Uk FazailAsma-e-Hasna Seekaho Aur Uk Fazail
Asma-e-Hasna Seekaho Aur Uk Fazail
 
20131028 BTUG.be - BizTalk Deployment
20131028 BTUG.be - BizTalk Deployment20131028 BTUG.be - BizTalk Deployment
20131028 BTUG.be - BizTalk Deployment
 
Internship presentation for sedf
Internship presentation for sedfInternship presentation for sedf
Internship presentation for sedf
 
Sud R B - TT - Kol
Sud R B - TT - KolSud R B - TT - Kol
Sud R B - TT - Kol
 

Semelhante a BAFF, Linfocitos B y Autoinmunidad

1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-mainHelene Schulz
 
Ablooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentAblooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentArarat Ablooglu
 
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...EuFMD
 
10.1101gad.1968110Access the most recent version at doi 2.docx
 10.1101gad.1968110Access the most recent version at doi 2.docx 10.1101gad.1968110Access the most recent version at doi 2.docx
10.1101gad.1968110Access the most recent version at doi 2.docxjoyjonna282
 
Smith,Jacob,MVB_Poster
Smith,Jacob,MVB_PosterSmith,Jacob,MVB_Poster
Smith,Jacob,MVB_PosterJacob Smith
 
BT proteins for non agricultural purposes
BT proteins for non agricultural purposesBT proteins for non agricultural purposes
BT proteins for non agricultural purposesSenthil Natesan
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?John Blue
 
Derivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsDerivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsOfer Wellisch
 
J. biol. chem. 2016-shao-jbc.m116.724401
J. biol. chem. 2016-shao-jbc.m116.724401J. biol. chem. 2016-shao-jbc.m116.724401
J. biol. chem. 2016-shao-jbc.m116.724401andrei andrei
 
Co-infection of epithelial cells established from the upper and lower bovine ...
Co-infection of epithelial cells established from the upper and lower bovine ...Co-infection of epithelial cells established from the upper and lower bovine ...
Co-infection of epithelial cells established from the upper and lower bovine ...andyheomoiandyheomoi
 
Xie's PaperASN2013070710SupplementaryData
Xie's PaperASN2013070710SupplementaryDataXie's PaperASN2013070710SupplementaryData
Xie's PaperASN2013070710SupplementaryDataPingtao Tang
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Meningitis Research Foundation
 
Cloning and sequence analysis of banana streak virus dna. harper 1998
Cloning and sequence analysis of banana streak virus dna. harper 1998Cloning and sequence analysis of banana streak virus dna. harper 1998
Cloning and sequence analysis of banana streak virus dna. harper 1998Paloma Susan
 
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...Delaina Hawkins
 

Semelhante a BAFF, Linfocitos B y Autoinmunidad (20)

1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main1-s2.0-S0014480015000970-main
1-s2.0-S0014480015000970-main
 
GKA deel 2 college 2
GKA deel 2 college 2GKA deel 2 college 2
GKA deel 2 college 2
 
Agro[2]
Agro[2]Agro[2]
Agro[2]
 
Ablooglu, AJ (2010) Development
Ablooglu, AJ (2010) DevelopmentAblooglu, AJ (2010) Development
Ablooglu, AJ (2010) Development
 
AAI Poster Preeyam
AAI Poster PreeyamAAI Poster Preeyam
AAI Poster Preeyam
 
CV v3.0
CV v3.0CV v3.0
CV v3.0
 
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...OS18 - 9.b.6  The use of reverse genetics to facilitate the growth of FMDV fo...
OS18 - 9.b.6 The use of reverse genetics to facilitate the growth of FMDV fo...
 
Seminar 08-10-2008 - wnt signaling system
Seminar 08-10-2008 - wnt signaling systemSeminar 08-10-2008 - wnt signaling system
Seminar 08-10-2008 - wnt signaling system
 
10.1101gad.1968110Access the most recent version at doi 2.docx
 10.1101gad.1968110Access the most recent version at doi 2.docx 10.1101gad.1968110Access the most recent version at doi 2.docx
10.1101gad.1968110Access the most recent version at doi 2.docx
 
Smith,Jacob,MVB_Poster
Smith,Jacob,MVB_PosterSmith,Jacob,MVB_Poster
Smith,Jacob,MVB_Poster
 
BT proteins for non agricultural purposes
BT proteins for non agricultural purposesBT proteins for non agricultural purposes
BT proteins for non agricultural purposes
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
 
Derivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsetsDerivation and functional characterization of distinct dc subsets
Derivation and functional characterization of distinct dc subsets
 
J. biol. chem. 2016-shao-jbc.m116.724401
J. biol. chem. 2016-shao-jbc.m116.724401J. biol. chem. 2016-shao-jbc.m116.724401
J. biol. chem. 2016-shao-jbc.m116.724401
 
Co-infection of epithelial cells established from the upper and lower bovine ...
Co-infection of epithelial cells established from the upper and lower bovine ...Co-infection of epithelial cells established from the upper and lower bovine ...
Co-infection of epithelial cells established from the upper and lower bovine ...
 
Xie's PaperASN2013070710SupplementaryData
Xie's PaperASN2013070710SupplementaryDataXie's PaperASN2013070710SupplementaryData
Xie's PaperASN2013070710SupplementaryData
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Cloning and sequence analysis of banana streak virus dna. harper 1998
Cloning and sequence analysis of banana streak virus dna. harper 1998Cloning and sequence analysis of banana streak virus dna. harper 1998
Cloning and sequence analysis of banana streak virus dna. harper 1998
 
1.1 philippe sansonetti
1.1 philippe sansonetti1.1 philippe sansonetti
1.1 philippe sansonetti
 
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...
Genetic Basis of Pyridoxine-Responsive Neonatal Epilepsy in Consanguineous Fa...
 

Mais de Rafael Ospina

Guía definitiva Maketing Digital Farmacéutico 2021-2022
Guía definitiva Maketing Digital Farmacéutico 2021-2022Guía definitiva Maketing Digital Farmacéutico 2021-2022
Guía definitiva Maketing Digital Farmacéutico 2021-2022Rafael Ospina
 
Marketing Digital en la industra farmacéutica
Marketing Digital en la industra farmacéuticaMarketing Digital en la industra farmacéutica
Marketing Digital en la industra farmacéuticaRafael Ospina
 
Visita Médica Virtual
Visita Médica VirtualVisita Médica Virtual
Visita Médica VirtualRafael Ospina
 
Transformacion Digital en Salud
Transformacion Digital en SaludTransformacion Digital en Salud
Transformacion Digital en SaludRafael Ospina
 
26. nuevo(completo) enfoque en el diagnotico de la osteoporosis
26. nuevo(completo) enfoque en el diagnotico de la osteoporosis26. nuevo(completo) enfoque en el diagnotico de la osteoporosis
26. nuevo(completo) enfoque en el diagnotico de la osteoporosisRafael Ospina
 
2. miopatia inflamatoria dr grau
2. miopatia inflamatoria dr grau2. miopatia inflamatoria dr grau
2. miopatia inflamatoria dr grauRafael Ospina
 
36. dr. lobelo. ondina marzo 2012
36. dr. lobelo. ondina marzo 201236. dr. lobelo. ondina marzo 2012
36. dr. lobelo. ondina marzo 2012Rafael Ospina
 
34. caracteristicas normales del dormir en rn y lactantes
34. caracteristicas normales del dormir en rn y lactantes34. caracteristicas normales del dormir en rn y lactantes
34. caracteristicas normales del dormir en rn y lactantesRafael Ospina
 
32. tratamientodeosteoporosis.ppt
32. tratamientodeosteoporosis.ppt32. tratamientodeosteoporosis.ppt
32. tratamientodeosteoporosis.pptRafael Ospina
 
31. presentacion caso version fina dra casas tp
31. presentacion caso version fina dra casas tp31. presentacion caso version fina dra casas tp
31. presentacion caso version fina dra casas tpRafael Ospina
 
30. otras herramientas en la evaluacion de osteoporosis tp
30. otras herramientas en la evaluacion de osteoporosis tp30. otras herramientas en la evaluacion de osteoporosis tp
30. otras herramientas en la evaluacion de osteoporosis tpRafael Ospina
 
29. osteoporosis en pediatría simposio cayre 2012 tp
29. osteoporosis en pediatría simposio cayre 2012 tp29. osteoporosis en pediatría simposio cayre 2012 tp
29. osteoporosis en pediatría simposio cayre 2012 tpRafael Ospina
 
28. osteoporosis en pediatría simposio cayre 2012
28. osteoporosis en pediatría simposio cayre 201228. osteoporosis en pediatría simposio cayre 2012
28. osteoporosis en pediatría simposio cayre 2012Rafael Ospina
 

Mais de Rafael Ospina (20)

Guía definitiva Maketing Digital Farmacéutico 2021-2022
Guía definitiva Maketing Digital Farmacéutico 2021-2022Guía definitiva Maketing Digital Farmacéutico 2021-2022
Guía definitiva Maketing Digital Farmacéutico 2021-2022
 
MOOCs en salud
MOOCs en saludMOOCs en salud
MOOCs en salud
 
Marketing Digital en la industra farmacéutica
Marketing Digital en la industra farmacéuticaMarketing Digital en la industra farmacéutica
Marketing Digital en la industra farmacéutica
 
Visita Médica Virtual
Visita Médica VirtualVisita Médica Virtual
Visita Médica Virtual
 
Transformacion Digital en Salud
Transformacion Digital en SaludTransformacion Digital en Salud
Transformacion Digital en Salud
 
Menntun Dossier
Menntun DossierMenntun Dossier
Menntun Dossier
 
Perez Campos
Perez CamposPerez Campos
Perez Campos
 
26. nuevo(completo) enfoque en el diagnotico de la osteoporosis
26. nuevo(completo) enfoque en el diagnotico de la osteoporosis26. nuevo(completo) enfoque en el diagnotico de la osteoporosis
26. nuevo(completo) enfoque en el diagnotico de la osteoporosis
 
2. miopatia inflamatoria dr grau
2. miopatia inflamatoria dr grau2. miopatia inflamatoria dr grau
2. miopatia inflamatoria dr grau
 
37. servo y avaps
37. servo y avaps37. servo y avaps
37. servo y avaps
 
36. dr. lobelo. ondina marzo 2012
36. dr. lobelo. ondina marzo 201236. dr. lobelo. ondina marzo 2012
36. dr. lobelo. ondina marzo 2012
 
35. cpap
35. cpap35. cpap
35. cpap
 
34. caracteristicas normales del dormir en rn y lactantes
34. caracteristicas normales del dormir en rn y lactantes34. caracteristicas normales del dormir en rn y lactantes
34. caracteristicas normales del dormir en rn y lactantes
 
33. bi pap
33. bi pap33. bi pap
33. bi pap
 
33. bi pap
33. bi pap33. bi pap
33. bi pap
 
32. tratamientodeosteoporosis.ppt
32. tratamientodeosteoporosis.ppt32. tratamientodeosteoporosis.ppt
32. tratamientodeosteoporosis.ppt
 
31. presentacion caso version fina dra casas tp
31. presentacion caso version fina dra casas tp31. presentacion caso version fina dra casas tp
31. presentacion caso version fina dra casas tp
 
30. otras herramientas en la evaluacion de osteoporosis tp
30. otras herramientas en la evaluacion de osteoporosis tp30. otras herramientas en la evaluacion de osteoporosis tp
30. otras herramientas en la evaluacion de osteoporosis tp
 
29. osteoporosis en pediatría simposio cayre 2012 tp
29. osteoporosis en pediatría simposio cayre 2012 tp29. osteoporosis en pediatría simposio cayre 2012 tp
29. osteoporosis en pediatría simposio cayre 2012 tp
 
28. osteoporosis en pediatría simposio cayre 2012
28. osteoporosis en pediatría simposio cayre 201228. osteoporosis en pediatría simposio cayre 2012
28. osteoporosis en pediatría simposio cayre 2012
 

BAFF, Linfocitos B y Autoinmunidad

  • 1.
  • 2. REAPPRAISAL OF BAFF IN AUTOIMMUNE CONDITIONS Pierre Youinou European University of Brittany, Brest, France
  • 3. T NF-like WEAK inducer of apoptosis ( TWEAK ) A Pr oliferation I nducing L igand ( APRIL ) B -cell A ctivation F actor of the TNF F amily ( BAFF ) TUMOR NECROSIS FACTOR FAMILY
  • 4.  
  • 5. SETTING THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
  • 6. THE CELL SOURCES OF BAFF Monocytes Macrophages Astrocytes Synoviocytes Dendritic cells Activated T lymphocyte Epithelial cells Neutrophils
  • 7. BR3 TACI BCMA HSPG BAFF SPECIFIC AND NON-SPECIFIC RECEPTORS APRIL BAFF BAFF APRIL APRIL Simone Forest 2010
  • 8. A VARIETY OF MOLECULES Furin BAFF APRIL TWEAK-PRIL TWEAK Daridon, Youinou et al, Autoimmun Rev 2007
  • 9. OVEREXPRESSION OF BAFF IN AUTOIMMUNE DISEASES Number of sera tested Proportion with increased level 94 192 126 52 57 2 Systemic lupus erythematosus patients Autoimmune disease controls Normal controls
  • 10. BAFF IS NOT Stohl et al, Arthritis Rheum 2003 Day of observation Day of observation Persistently elevated serum BAFF Intermittently elevated serum BAFF CONSTANT
  • 11.
  • 12. Menbrane-bound Cell-free BAFF APRIL Glycosylated or not - + PNGaseF 28 21 Anti-BAFF Complexes Virus-like clusters Rochas, Youinou et al, Arthritis Rheum, 2009 Roschke et al, J Immunol, 2004 Le Pottier, Youinou et al, submitted Liu et al, Cell, 2002 BAFF ? Receptor for BAFF Alternative splices 28 17 TFMS - + Rabbit - + Goat BAFF IS NOT RECOGNIZED
  • 13. IN-HOUSE ELISA FOR BAFF Le Pottier, Youinou et al, Clin Chem 2009 28 21 S#1 S#2 Rabbit Ab S#1 S#2 Mouse Ab 28 21 Absorbance (492nm) 0 1 2 3 BAFF (  g/L) 0.1 1 10 100 Goat / Rabbit-biot Goat / Goat-biot Rabbit / Rabbit-biot Rabbit / Goat-biot
  • 14. SETTING THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
  • 15. BAFF-MEDIATED B-CELL HOMEOSTASIS PROLIFERATION BAFF Tg TNF-/- BAFF Tg DIFFERENTIATION CD40-dependent CD40 +IL-4 BAFF CD40-independent BAFF no BAFF yes SSC SURVIVAL ACTIVATION
  • 16. BT1 BT2 High affinity BCR Low affinity BCR Lymphoid follicle germinal center Marginal zone Pre-B MARGINAL ZONE B CELLS AT RISK OF BEING ACTIVATED Apoptosis BAFF
  • 17. MICE TRANSFECTED WITH cDNA FOR HUMAN BAFF Groom, Mackay et al, J Clin Invest 2002 1/1280
  • 18. Walters et al, J Immunol, 2009 BAFF-INDUCED REGULATORY T CELLS WT BAFF-Tg CD4 + Foxp3 +
  • 19. SETTING THE SCENE FOR BAFF KNOWN ACTIVITIES OF BAFF REGULATION OF BAFF PRODUCTION
  • 20. DISCOVERY OF A NEW mRNA FOR BAFF 3’ RACE-PCR ? Exon 5 Exon 3 748 862 Δ 4 BAFF 1 2 4 3 5 6 BAFF Δ BAFF φ BAFF
  • 21. Δ 4 (D->124) LOCATION OF THE NEW PROTEIN GFP Δ 4 RAMOS BAFF pIRES Δ 4 WT 21 kDa 17 kDa Mouse anti-BAFF Rabbit anti-BAFF BAFF Δ 4 BAFF
  • 22. Cold probe (20x) Mouse anti-BAFF Nuclear extract - - - - + - - + - - - + - + - + Rabbit Anti-BAFF - - + + Supershift Shift Δ 4BAFF IS A TRANSCRIPTION FACTOR
  • 23. TRUNCATED BAFF TRANSPORTS TRANSCRIPTION FACTOR(S) FOR FULL-LENGTH BAFF INTO THE NUCLEUS Le Pottier, Tob ón, Mackay, Youinou and Pers , submitted Rabbit Mouse -1600 ATG CD40 NF- κ B subunits Negative control Positive control  actin Mouse Plas Δ 4 wt Mouse/ β -actin 0.85 0.90 1.24 0.86 Rabbit Rabbit/ β -actin 0.83 0.90 1.57 0.70 1 1
  • 24. mRNA for Δ 4 BAFF Δ 4 BAFF protein product Full-length BAFF Transcription factor
  • 25.
  • 26.  

Notas do Editor

  1. BAFF_Colombie mars 2011
  2. BAFF_Colombie mars 2011
  3. BAFF_Colombie mars 2011
  4. BAFF_Colombie mars 2011